Publications internationales

1.H. BENBAIBECHE, H. SAIDI, A. BOUNIHI, EA. KOCEIR

Emotional and external eating styles associated with obesity.

Journal of Eating Disorders, 2023, 11 (1), 1-7. IF:  4.916. https://pubmed.ncbi.nlm.nih.gov/37131270/

2.A. BOUAZZA, E. FONTAINE, X. LEVERVE, EA. KOCEIR. Interference of plasma altered trace elements profile with hyperhomocysteinemia and oxidative stress damage to insulin secretion dysfunction in Psammomys obesus: Focus on the selenium.

Arch Physiol Biochem, 2023; 10:1-14.  IF: 2.575. https://pubmed.ncbi.nlm.nih.gov/33171059/

3.A. BOUAZZA, A. TAHAR, S. AITABDERRHMANE, M. SAIDANI, EA. KOCEIR.

11.H. BENBAIBECHE, A. BOUNIHI, EA. KOCEIR.

Leptin level as a biomarker of uncontrolled eating in obesity and overweight.

Ir J Med Sci, 2020; IF: 1.224. https://pubmed.ncbi.nlm.nih.gov/32681271/

12.H. BENBAIBECHE, A. HICHAMI, B. OUDJIT, EM. HAFFAF, G. KACIMI, EA. KOCEÏR, NA. KHAN.

Circulating mir-21 and mir-146a are associated with increased cytokines and CD36 in Algerian obese male participants.

Arch Physiol Biochem. 2020, ;13:1-6. IF: 2.575. https://pubmed.ncbi.nlm.nih.gov/32536220

14.H. SAIDI, A. BOUNIHI, A. BOUAZZA, A. HICHAMI, EA. KOCEIR, NA. KHAN.

Spirulina reduces diet-induced obesity through downregulation of lipogenic genes expression in Psammomys obesus.

Arch Physiol Biochem. 2020 Mar 24:1-9. IF: 2.575 https://pubmed.ncbi.nlm.nih.gov/32207345

15.S. CHELLALI, A. BOUDIBA, L. GRIENE, EA. KOCEIR.

Incretins-adipocytokines interactions in type 2 diabetic subjects with or without non-alcoholic fatty liver disease: Interest of GLP-1 (Glucagon-like peptide-1) as a modulating biomarker. 77(3):261-271. Ann Biol Clin 2019. IF: 0.503. https://www.ncbi.nlm.nih.gov/pubmed/30998190

16.I. L’HADJ, R. AZZI, F. LAHFA, EA. KOCEIR , N. OMARI.

The nutraceutical potential of Lepidium sativum L. seed flavonoid‐rich extract in managing metabolic syndrome components.

Journal of Food Biochemistry 2018; e12725. IF: 1.662 https://onlinelibrary.wiley.com/doi/abs/10.1111/jfbc.12725

17.A. LABDI, M. AMIALI, NAIT Y.BACHIR, A.MEROUANE, A.DAHMAN-ZOUAMBI, EA. KOCEIR , A. BITAM

Green tea extract attenuates non alcoholic fatty liver disease by decreasing hyperlipidemia and enhancing Superoxide dismutase activity in cholesterol-fed rats.

Mediterranean Journal of Nutrition and Metabolism 1:12. 2018 IF: 0.730

https://content.iospress.com/articles/mediterranean-journal-of-nutrition-and metabolism/mnm180227

18.A. GHENNAI, EA.KOCEIR, S. AOUICHAT-BOUGUERRA, S. BOUDERBA.

Arthrospira platensis improves macrophages arginine metabolism and prevents insulin resistance in Psammomys obesus.

Progress in Nutrition 2018. 19 (4), 436-441. IF: 0.344. http://www.mattioli1885journals.com/index.php/progressinnutrition/article/view/6211

19.A. TAHAR, F. ZERDOUMI, M. SAIDANI, L. GRIENE, EA. KOCEIR

Effects of oral vitamin D₃ supplementation in stage 3 Chronic Kidney Disease subjects: Insulin resistance syndrome and hormonal disturb interactions.

Ann Biol Clin 2018; 76(3):313-325. IF: 0.401. https://www.ncbi.nlm.nih.gov/pubmed/29661746

20.L. OULD AMARA-LEFFAD, H. RAMDANE, K. NEKHOUL, A. OUZNADJI, EA. KOCEIR .

Spirulina effect on modulation of toxins provided by food, impact on hepatic and renal functions.

Arch Physiol Biochem. 2018 Feb 27:1-11. IF: 1,220. https://www.ncbi.nlm.nih.gov/pubmed/29484960

21.K. TABANI, Z. BIREM, H. HALZOUNE, W. SAIAH, F. LAHFA, EA. KOCEIR , N. OMARI.

Therapeutic effect of alkaloids and glycosides of colocynth seeds on liver injury, associated with metabolic syndrome in wistar rats, subject to nutritional stress.

Pak J Pharm Sci. 2018 Jan; 31(1(Suppl.)):277-290. IF: 0,762. https://www.ncbi.nlm.nih.gov/pubmed/29386155

22.W. SAIAH, H. HALZOUNE, R. DJAZIRI, K. TABANI, EA. KOCEIR, N. OMARI.

Antioxidant and gastroprotective actions of butanol fraction of Zingiber officinale against diclofenac sodium‐induced gastric damage in rats.

Journal of Food Biochemistry 2017. 42 (1), e12456. http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1745-4514

23.I. GOUAREF, D. DETAILLE, N. WIERNSPERGER, NA. KHAN, X. LEVERVE, EA. KOCEIR.

The desert gerbil Psammomys obesus as a model for metformin-sensitive nutritional type 2 diabetes to protect hepatocellular metabolic damage: Impact of mitochondrial redox state.

PLoS One; 12(2):e0172053. doi: 10.1371/journal.pone.0172053, 2017. IF: 3,057. https://www.ncbi.nlm.nih.gov/pubmed/28222147

24.A.F BENNACER, EM. HAFFAF, G. KACIMI, B. OUDJIT, EA. KOCEIR

Association of Polyunsaturated / Saturated Fatty Acids to Metabolic Syndrome Cardiovascular Risk Factors and Lipoprotein (a) in Hypertensive Type 2 Diabetic Patients.

Ann Biol Clin 2017; 74(3):293-304. IF: 0.415. https://www.ncbi.nlm.nih.gov/pubmed/28540852

25.Z. BIREM, K. TABANI, F. LAHFA, R. DJAZIRI, F. HADJBEKKOUCHE, EA. KOCEIR , N.OMARI.

Effects of colocynth alkaloids and glycosides on Wistar rats fed high-fat diet. A biochemical and morphological study. Folia Histochem Cytobiol. 2017;55(2):74-85. IF: 1.389. https://www.ncbi.nlm.nih.gov/pubmed/28691730

26.A. BOUNIHI, A. BITAM, A. BOUAZZA, L. YARGUI, EA. KOCEIR

Fruit vinegars attenuate cardiac injury via anti-inflammatory and anti-adiposity actions in high-fat diet-induced obese rats.

Pharm Biol, 5:1-10, 2016. IF: 1,546. https://www.ncbi.nlm.nih.gov/pubmed/27595296

27.I. GOUAREF, Z. BELLAHSENE, S. ZEKRI, B. ALAMIR, EA. KOCEIR

The link between trace elements and metabolic syndrome/oxidative stress in essential hypertension

with or without type 2 diabetes.

Ann Biol Clin. 2016; 73(2):233-43. IF: 0.415. https://www.ncbi.nlm.nih.gov/pubmed/27029728

28.A. BOUAZZA, A. BITAM, AMIALI M, A. BOUNIHI, L. YARGUI, EA. KOCEIR

Effects of fruit vinegars on liver damages and oxidative stress in high fat fed rats.

Pharm Biol, 54:260 -265, 2015. IF: 1,337.

http://www.ncbi.nlm.nih.gov/pubmed/25853952

29.N. MAOUCHE, D. MESKINE, B. ALAMIR, EA. KOCEIR

Trace elements profile is associated with insulin resistance syndrome and oxidative damage in thyroid disorders: Manganese and selenium interest.

J Trace Elem Med Biol, 32:112–121, 2015, IF: 2.371 https://www.ncbi.nlm.nih.gov/pubmed/26302919

30.H. ZOUBIRI, EM. HAFFAF, G. KACIMI, B. OUDJIT, N. ADJEROUD, EA. KOCEIR

Cardiometabolic and Cardiorenal syndromes interactions in Algerian diabetic- hypertensive patient: Interest of predictive multi-biomarkers strategy to renal dysfunction.

Ann Biol Clin (Paris), 73: 443 – 53, 2015. IF: 0.415.

http://www.ncbi.nlm.nih.gov/pubmed/25119805

31.H. BENBAIBECHE, EM. HAFFAF, G. KACIMI, B. OUDJIT, NA. KHAN,EA. KOCEIR

Implication of corticotropic hormone axis in eating behaviour pattern in obese and type 2 diabetic participants.

British Journal of Nutrition, 18:1-7, 2015. IF: 3,342. https://www.ncbi.nlm.nih.gov/pubmed/25782454

32.F. ATEK-MEBARKI, A. HICHAMI, A. BITAM, EA. KOCEÏR, NA. KHAN

Eicosapentaenoic acid modulates fatty acid metabolism and inflammation in Psammomys obesus. Biochimie, 109: 60-66, 2015. IF: 3.123. https://www.ncbi.nlm.nih.gov/pubmed/25528298

33.H. BENBAIBECHE, EM. HAFFAF, G. KACIMI, B. OUDJIT, EA. KOCEIR

Pathophysiological characterization of metabolic syndrome in overweight,obese and type 2 diabetic Algerian subjects: Interest of adipokines as dysmetabolic biomarkers.

Ann Biol Clin (Paris), 72(4):463-472. 2014. IF: 0.415.

http://www.ncbi.nlm.nih.gov/pubmed/25119805

34.S. BOUDERBA, C. SANCHEZ-MARTIN, G.R. VILLANUEVA,D. DETAILLE, E.A KOCEÏR.

Beneficial effects of silibinin against the progression of metabolic syndrome, increased oxidative stress, and liver steatosis in Psammomys obesus, a relevant animal model of human obesity and diabetes.

Journal of Diabetes, vol 6, pages 184–192, 2014. IF: 2.939. https://www.ncbi.nlm.nih.gov/pubmed/23953934

35.S. ABDOUL-AZIZE, F. ATEK-MEBARKI, A. BITAM, H. SADOU, EA. KOCEÏR, NA. KHAN

Oro-gustatory perception of dietary lipids and calcium signaling in taste bud cells are altered in nutritionally obesity-prone Psammomys obesus. 

PLOS One, 8 :e68532, 2013. IF: 3.730. https://www.ncbi.nlm.nih.gov/pubmed/23936306

36.H. HARANI, A. OTMANE, M. MAKRELOUF, N. OUADAHI, A. ABDI, A. BERRAH, A. ZENATI, B. ALAMIR, EA KOCEÏR. 

Primary evaluation of antioxidant status oligomineral patient with type 2 diabetes Algeria: special interest manganese and chromium.  

Ann Biol Clin (Paris), 70:669-677, 2012. IF: 0.443. https://www.ncbi.nlm.nih.gov/pubmed/23207812

37.S. BOUDERBA, M. NIEVES SANZ, C. SANCHEZ-MARTIN, D. DETAILLE, G.R. VILLANUEVA, E.A KOCEÏR

Hepatic mitochondrial alterations and increased oxidative stress in nutritional diabetes prone Psammomys obesus model.

Experimental Diabetes Research, 2012:430176, 2012. IF: 1.528. https://www.ncbi.nlm.nih.gov/pubmed/22675340

38.EA. KOCEIR, H. BENBAÏBECHE, M. HAFFAF, G. KACIMI, B. OUDJIT.

Primary evaluation of the behaviour eating disorder in obese and type 2 diabetic Algerian subjects. Ann Biol Clin (Paris), 67 (3): 307-13, 2009. IF: 0.443. https://www.ncbi.nlm.nih.gov/pubmed/19411233

39.EA. KOCEIR, H. BENBAÏBECHE, M. HAFFAF, G. KACIMI, B. OUDJIT.

Metabolic syndrome and hormonal interaction in obese and type 2 diabetic Algerian subject. The behaviour eating disorder impact.

Ann Biol Clin (Paris), 67 (3): 315-23, 2009. IF: 0.443. https://www.ncbi.nlm.nih.gov/pubmed/19411234

40.BELARBI C., MAKRELOUF M., OTMANE A., CHERIFI ME., ALAMIR B., ZENATI A., KOCEIR EA 

Stress oxydant et homocysteine : Corrélation entre l’Homocysteinemie et les concentrations sériques en oligo-éléments anti-oxydants chez le patient diabétique de type 2. XII ^es Journées nationales Homocystéine Toulouse – 4 et 5 octobre 2007 

Ann Biol Clin, Volume 66, N° 6, 2008 IF : 0.443

www.revue-abc.com

41.KOCEIR EA, LEVERVE XM

Eco-physiological role of insulin resistance in energetic metabolism adaptation of natural hypocaloric conditions in Sand rat, Psammomys obesus.  

Bulletin de la Société Zoologique de France, 131, Vol., N°1, 23-42, 2006. IF : 0.240

http://www.snv.jussieu.fr/zoologie/ ou http://sumaris.cbuc.es  ou http://direct.bl.uk

42.EA KOCEIR, Y. DAHMANI and X. LEVERVE

Low rate of glucose 6-phosphate hydrolysis in liver cells is a physiological feature of non-diabetic wild Psammomys obesus.

Diabetes Metabolism, 29, 1-12, 2003. IF: 1.546. https://www.ncbi.nlm.nih.gov/pubmed/14526264

43.XM. LEVERVE, B. GUIGAS, D. DETAILLE, C. BATANDIER, EA KOCEIR, C. CHAUVIN, E. FONTAINE and NF. WIERNSPERGER. Mitochondrial metabolism and type-2 diabetes: a specific target of metformin.

Diabetes Metabolism, 29, 6S00-6S00, 2003. IF: 1.546. https://www.ncbi.nlm.nih.gov/pubmed/14502105